Work

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

Year: 1985

Type: article

Study design: Clinical Trial

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.134.1.157

Authors: M T Lotze, L W Frana, S O Sharrow, R J Robb, S A Rosenberg

Institutions: National Institutes of Health, National Cancer Institute, DuPont (United States)

Language: English

Topic: T-cell and B-cell Immunology

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1600577617

FWCI: 14.74

Cites:

Cited by: 387

Related to: 10